JUSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Jushi Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$0.49−0.03 (-5.50%)
Close on Oct 19, 2026
- Market cap
- $98.11M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.2550 (−34.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Jushi Holdings Inc. grew revenue 6.0% to $271.75M over the twelve months to Jun 30, 2026. Operating income rose 7529.6% to $5.42M, moving the operating margin from 0.0% to 2.0%. Free cash flow was $6.66M, up 64.7% from a year earlier.
Revenue
$271.75M
+6.0% vs. a year earlier
Operating income
$5.42M
+7529.6% vs. a year earlier
Free cash flow
$6.66M
+64.7% vs. a year earlier
EPS, diluted
-$0.35
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $98.11M
- P/E ratio
- –
- Price to sales
- 0.36
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 6.78%
Fundamentals
- Revenue
- $271.75M
- Net income
- -$68.59M
- EPS, diluted
- -$0.35
- Free cash flow
- $6.66M
- Book value per share
- -$0.72
- Diluted shares
- 198M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$271.75M+6.0% YoY
Gross profit
$120.69M+11.6% YoY
Operating income
$5.42M+7529.6% YoY
Net income
–
EPS, diluted
–
Free cash flow
$6.66M+64.7% YoY
Reported periodTrailing twelve months